genXone S.A. (WSE:GX1)
Poland · Delayed Price · Currency is PLN 5.94
-0.02 (-0.34%)
Last updated: May 15, 2026, 10:40 AM CET
genXone Market Cap
genXone has a market cap or net worth of 19.63 million as of May 15, 2026. Its market cap has increased by 12.08% in one year.
Market Cap
19.63M
Enterprise Value
16.27M
Revenue
2.34M
Ranking
n/a
PE Ratio
n/a
Stock Price
5.94
Market Cap Chart
Since September 4, 2020, genXone's market cap has decreased from 141.69M to 19.63M, a decrease of -86.14%. That is a compound annual growth rate of -29.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 19.63M | 48.87% |
| Dec 30, 2025 | 13.19M | -35.65% |
| Dec 30, 2024 | 20.49M | 15.53% |
| Dec 29, 2023 | 17.74M | -47.33% |
| Dec 30, 2022 | 33.67M | -51.33% |
| Dec 30, 2021 | 69.20M | 0.10% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 4, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Diagnostyka | 5.37B |
| NEUCA | 3.19B |
| Synektik Spólka Akcyjna | 2.39B |
| Celon Pharma | 1.13B |
| Airway Medix | 34.99M |
| SDS Optic Spolka Akcyjna | 32.63M |
| Pure Biologics | 29.51M |
| Medicofarma Biotech | 29.09M |